BlackRock Amends BMS Stake: Passive Investment Update
Ticker: CELG-RI · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 14272
| Field | Detail |
|---|---|
| Company | Bristol Myers Squibb Co (CELG-RI) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, pharmaceuticals
TL;DR
**BlackRock updated its passive stake in Bristol Myers Squibb, signaling a minor portfolio adjustment.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 25, 2024, indicating a change in its ownership of Bristol Myers Squibb Co. common stock as of December 31, 2023. This amendment, number 14, shows BlackRock's updated passive investment position in the pharmaceutical giant. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding Bristol Myers Squibb, potentially influencing other investors.
Why It Matters
Large institutional investors like BlackRock often influence market sentiment; their updated holdings can signal confidence or caution in a stock.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate or significant risk to the company or its stock.
Analyst Insight
Investors should note that BlackRock's continued passive ownership suggests a long-term, stable view of Bristol Myers Squibb, but this filing alone doesn't warrant immediate action.
Key Players & Entities
- BlackRock Inc. (company) — the entity filing the SC 13G/A, reporting its ownership in Bristol Myers Squibb Co.
- BRISTOL MYERS SQUIBB CO (company) — the subject company whose common stock is being reported on
- December 31, 2023 (date) — the date of the event which required the filing of this statement
- January 25, 2024 (date) — the date the SC 13G/A filing was made
- 110122108 (number) — the CUSIP number for Bristol Myers Squibb Co. Common Stock
Forward-Looking Statements
- BlackRock will continue to hold a significant, passive stake in Bristol Myers Squibb Co. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It generally indicates that a passive institutional investor, like BlackRock Inc., has updated its ownership position in a company, in this case, BRISTOL MYERS SQUIBB CO, as of a specific date (December 31, 2023).
Who is the reporting entity in this filing?
The reporting entity is BlackRock Inc., a major asset manager with a business address at 50 Hudson Yards, New York, NY 10001.
Which company's stock is the subject of this filing?
The subject company is BRISTOL MYERS SQUIBB CO, a pharmaceutical preparations company with a business address at Route 206 and Province Line Road, Princeton, NJ 08543.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, indicating the ownership position being reported is as of the end of last year.
What rule under the Securities Exchange Act of 1934 is this Schedule 13G filed under?
This Schedule 13G is filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, which typically applies to institutional investors who acquire beneficial ownership of more than 5% of a class of a company's equity securities in the ordinary course of business and without the purpose or effect of changing or influencing control of the issuer.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding BRISTOL MYERS SQUIBB CO (CELG-RI).